Cognition.

Psychopharmacology logo

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition

Main results: Cannabis containing equivalent concentrations of CBD and THC appears no less impairing than THC-dominant cannabis, and in some ...
Read more…
Drug Testing and Analysis logo

Orally administered cannabidiol (CBD) does not produce false‐positive tests for THC on the Securetec DrugWipe® 5S or Dräger Drug Test® 5000

Main results: Orally administered CBD does not appear to produce false-positive (or true-positive) tests for THC on the DW-5S and ...
Read more…
Accident Analysis & Prevention logo

Simulated driving performance among daily and occasional cannabis users

Main results: Occasional users had a similar drug effect as daily users but lower blood THC. Smoked cannabis led to ...
Read more…
Brain and Behavior logo

The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity

Main results: THC:CBD oromucosal spray was shown not to impair driving performance.*Posology used: 1 to 16 actuations (2.7 mg THC ...
Read more…
Neuroscience & Biobehavioral Reviews logo

Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review

Main results: Most driving-related skills are predicted to recover within ∼5-hs (and almost all within ∼7-hs) of inhaling 20 mg Δ9-THC ...
Read more…